Indication

Measles-mumps-rubella vaccination

Measles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus. Read more about Measles-mumps-rubella vaccination

7 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Measles-mumps-rubella vaccination therapies.

Showing 1–7 of 7 drugs

Filter & compare in the drug finder →Opens the drug finder with Measles-mumps-rubella vaccination preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Measles-mumps-rubella vaccination.

Measles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus.

It is primarily administered across pediatric populations starting at 12 months of age, as well as to susceptible adolescents and adults.

These targeted viral pathogens cause acute systemic infections marked by respiratory spread, high fever, maculopapular rash, and parotitis.

Vaccination prevents severe pathophysiologic complications associated with these diseases, such as viral pneumonia, encephalitis, aseptic meningitis, orchitis, and congenital rubella syndrome resulting from gestational transmission.

Personalize your experience

Follow Measles-mumps-rubella vaccination and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it